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Introduction 
Porokeratotic eccrine ostial and dermal duct nevus 
(PEODDN) is a rare dermatosis initially described in 
1979 as 'comedo nevus' [1] and it was renamed 
'PEODDN' in 1980 [2]. It has also been referred to as 
linear eccrine nevus with comedones [3], 
porokeratotic eccrine ostial and hair follicle nevus [4], 
and porokeratotic adnexal ostial nevus [5]. Most 
cases of PEODDN are present at birth or develop 
during childhood [6]. Rarely, PEODDN can develop in 
adults.  
 
Case Synopsis 
A 38-year-old woman was referred to us for skin 
lesions that had appeared three years prior on her 
left upper limb. Physical examination showed an 
erythematous-pink, slightly hyperkeratotic, rather 
well-limited elongated plaque on the radial side of 
her left thumb, extending to the wrist (Figure 1A). 
Dermatoscopic examination showed an 
erythematous plaque studded with several distinct 
whitish pinhead-sized globules (Figure 1B). The 
patient reported mild occasional pruritus, which was 
unrelated to her work and showed no clear seasonal 
variations. She mentioned that similar lesions had 
appeared previously on the same extremity (forearm 
and arm) but had regressed spontaneously. The 
patient was otherwise in good condition, had no 
other mucocutaneous lesions, and was not taking 
systemic treatments. She had two healthy children 
(aged 8 and 10 years) and her family history was 
unremarkable. Her lesions had been treated by her 
family physician with topical corticosteroids, which 
Abstract 
Porokeratotic eccrine ostial and dermal duct nevus 
(PEODDN) is a rare dermatosis initially described as 
‘comedo nevus’ and renamed ‘PEODDN’; it has also 
been referred to as linear eccrine nevus with 
comedones, porokeratotic eccrine ostial and hair 
follicle nevus, and porokeratotic adnexal ostial nevus. 
PEODDN is usually present at birth or develops early 
in life. Rarely, PEODDN can develop in adults. The 
treatment of this puzzling condition is not 
standardized. We report herein a new case of adult-
onset PEODDN with dermatoscopic images. Our 
patient responded favorably to topical tazarotene. 
 
Figure 1. A) Clinical appearance of the lesion: erythematous-
pink, slightly hyperkeratotic, well-limited elongated plaque on the 
radial side of the thumb, extending to the wrist. B) Dermatoscopic 
examination shows an erythematous plaque studded with 
several whitish pinhead-sized globules. C) Clinical improvement 
after a one-month treatment with 0.1% tazarotene gel.  
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alleviated pruritus, but had no obvious effect on the 
appearance of the plaque. Microscopic examination 
of a punch skin biopsy showed epidermal 
hyperplasia (hyperkeratosis, acanthosis, 
papillomatosis) and parakeratotic plugs within 
dilated, hyperplastic eccrine sweat-gland ostia 
(Figure 2A, B). A lymphocytic infiltrate was present 
in the dermis, surrounding the superficial part of the 
excretory eccrine sweat gland ducts and the eccrine 
sweat gland coil (Figure 2C). These findings were 
diagnostic of PEODDN. The patient was prescribed 
treatment with daily applications of tazoretene 0.1% 
gel. After one month, the lesions had improved, 
showing less erythema and surface hyperkeratosis 
(Figure 1C). The treatment was well-tolerated and 
the patient was advised to continue the treatment 
for another month. 
 
Case Discussion 
PEODDN, first described as 'comedo nevus of the 
palm' [1], is a rare condition of which about 70 cases 
have been reported in the literature. Most cases are 
present at birth or develop within the first two 
decades of life [6]. Seven cases [7-13] had their onset 
in adulthood, at a mean age of 31 years (range, 18-
65). Our patient is therefore the 8th case of adult-
onset PEODDN reported in the literature (Table 1). 
PEODDN affects almost equally both genders, but 
the adult onset cases show a slight male 
predominance (5:3). It presents clinically with 
unilateral, verrucous or keratotic, pink, brown, or 
whitish pits with comedo-like plugs or papules, 
located primarily on the extremities, particularly the 
palms and soles [7-11, 13-15]. The lesions are more 
rarely bilateral. They may coalesce into linear plaques 
[8], sometimes following Blaschko lines [5, 7, 16], and 
have thereby been considered as a variant of linear 
porokeratosis by virtue of a similar pathological 
appearance. The lesions are usually asymptomatic 
[10, 13, 14] but may be mildly pruritic as in our 
patient [8, 9]. The clinical differential diagnosis of 
PEODDN includes dermatoses with linear 
distribution, such as epidermal nevi, linear psoriasis, 
linear Darier disease, linear lichen planus, and 
ichthyotic disorders with a Blaschkoid distribution, 
such as Conradi-Hünermann-Happle and CHILD 
syndrome [8, 13]. Dermatoscopic examination may 
assist the diagnosis by showing whitish pinhead-
sized dots (corresponding to the surface of the 
cornoid lamellae embedded in eccrine ostia) over a 
slightly erythematous background. The definite 
diagnosis requires microscopic examination, which 
shows a variable degree of epidermal hyperplasia 
(hyperkeratosis, acanthosis, papillomatosis) and the 
presence of cornoid lamellae (narrow vertical stacks 
of parakeratotic corneocytes) within eccrine sweat 
gland ostia. A lymphocytic infiltrate may surround 
the eccrine gland, as in our case, and highlights the 
involvement of the eccrine gland in the 
development of this condition. The presence of 
cornoid lamellae confined to adnexal ostia 
differentiates PEODDN from other porokeratosis 
forms, in which the cornoid lamella is not confined to 
adnexal ostia [17]. 
The etiopathogenesis of PEODNN remains poorly 
known. It has been proposed that the lesions of 
porokeratosis result from the peripheral expansion 
of a clone of mutant epidermal keratinocytes located 
at the base of the cornoid lamella [17]. It can be 
speculated that the same mechanism could underlie 
PEODDN if the mutant keratinocytes reside within 
eccrine glands. Our finding of lymphocytic 
infiltration around eccrine glands is consistent with 
 
Figure 2. A, B) Microscopic examination of a skin biopsy shows 
two keratin parakeratotic plugs (cornoid lamellae) within dilated 
eccrine gland ostia. The upper dermis contains a lymphocytic 
infiltrate surrounding the superficial part of excretory eccrine 
sweat gland ducts. C) The infiltrate also surrounds the deep 
dermal eccrine sweat-gland coil. H&E, A) 100×, B) 200×, C) 400×. 
A 
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this hypothesis. Heredity may play a role since one 
familial case has been reported [18]. The distribution 
of PEODDN lesions along the lines of Blaschko 
suggests that genetic mosaicism may play a role [19]. 
More recently, it was found that PEODDN is caused 
by somatic mutations in the gene GJB2 encoding for 
connexin 26 [20], a gap junction protein, which 
permits intercellular ion and macromolecule flux. 
Porokeratotic eccrine ostial and dermal duct nevus, 
especially when systematized or bilateral, can be 
associated with various conditions, including 
hyperthyroidism and sensory polyneuropathy [7], 
breast hypoplasia [21], deafness, developmental 
delay [22], alopecia, onychodysplasia [23], psoriasis 
[24], palmoplantar keratoderma [25], hemiparesis, 
and scoliosis [26]. Whether or not these associations 
are fortuitous remains speculative. The association of 
PEODDN with KID (keratosis, ichthyosis, deafness) 
syndrome [27] is interesting and seems significant 
since this complex genetic disease is also related to  
mutations of the GBJ2 gene. It has been suggested 
that patients carrying GBJ2 somatic mosaicism are at 
risk for transmitting systemic disease to their 
offspring and that all individuals with PEODDN 
should therefore be counseled regarding the risk of 
having a child with KID syndrome [20]. 
The course of PEODDN is chronic. The lesions may 
remain stable over years [8, 10] or be slightly 
progressive [12]. Our patient experienced 
spontaneous regression of part of her lesions on the 
arm and forearm. The prognosis is as a rule benign; 
however, transformation of PEODDN into Bowen 
disease [28] and squamous cell carcinoma [29, 30] 
has been reported. This fact is consistent with the 
contention that PEODDN may be a form of linear 
porokeratosis, known to be at risk for malignant 
transformation [17]. 
The treatment of PEODDN is challenging as no 
standardized option exists. Various treatments have  
Table 1. Cases of adult-onset porokeratotic eccrine ostial and dermal duct nevus published in the literature. 
Case  Ref 
Gender/ 
Age at 
onset Location Aspect of lesions Associated conditions 
Treatment/ 
Outcome 
1  [7] M/65 R palm linearly-arranged yellow-grey keratotic papules  
Hyperthyroidism, 
sensory polyneuropathy nm/nm 
2  [8] M/18 L forearm, arm, upper chest 
linearly-arranged 
brownish verrucous 
papules, nodules and 
plaques, punctate palmar 
pits 
none ablative laser therapy/nm 
3  [9] M/21 R lateral ankle 
pruritic keratotic papules 
linearly distributed to 
form plaques 
nm nm/nm 
4  [10] F/27 
L upper limb 
(index finger, 
hand dorsum, 
forearm) 
multiple hyperpigmented 
keratotic papules discrete 
or coalescing to plaques 
pits and groove of the 
nail of the index finger nm/nm 
5 [11] F/29 L foot Keratotic papules and pits, some with keratotic plugs  none nm/nm 
6  [12] M/ mid 30’s R buttock 
well-demarcated 2-cm 
plaque with multiple 3- to 
4-mm-thick yellow-brown 
hornlike projections 
poorly-controlled type II 
diabetes mellitus, heavy 
tobacco smoking 
urea 40% cream: little 
improvement, shave 
removal: no recurrence 
12 months later 
7  [13] M/30 L hand 
punctate pits, keratotic 
papules and verrucous 
plaques 
none topical keratolytics, emollients/ nm 
8  
This 
case F/35 L wrist 
Pink, well-demarcated 
plaque with a keratotic 
surface
none 
tazarotene 0.1% gel/ 
improvement 
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been used, but none seems to be regularly effective 
[6]. Topical corticosteroids (methylprednisolone and 
clobetasol propionate) can achieve temporary relief 
[31, 32]. Local tretinoin 1% cream, calcipotriene 
ointment [32], 5-fluorouracil [5], and various 
keratolytics have been used, including urea 
ointment or cream [12] and salicylic acid in 
petrolatum [15], without significant results. Systemic 
acitretin (50mg/d for two months) was ineffective in 
one case, although it improved the pruritus [15]. 
Partial results have been obtained with 
photodynamic therapy [33]. Carbon dioxide laser [6, 
8, 16] alone or combined with erbium [34] have 
provided good results, especially for large lesions. 
Topical tazarotene has been tried in three patients, 
as 0.1% gel or 0.05% or 0.1% cream (Table 2). Two 
patients showed minimal response [5], but another 
patient achieved almost complete response within 
three weeks [28]. We decided to try this treatment in 
our patient since it can provide good results in 
various (genetic or acquired) diseases of 
keratinization and our patient obtained encouraging 
results. The systemic absorption of tazarotene after 
local application to small skin areas seems to be 
limited, nevertheless a pregnancy test is 
recommended prior to the onset of treatment in 
women of childbearing potential. The drug is 
contraindicated in women who are pregnant or 
desire a pregnancy. 
 
Conclusion 
Porokeratotic eccrine ostial and dermal duct nevus 
can rarely appear in adults but should be considered 
in the differential diagnosis of acral keratotic lesions 
appearing in adulthood. The diagnosis is usually 
made by histological examination. Although no 
regularly effective standard treatment exists our 
observation suggests that tazarotene 0.1% gel may 
be a satisfactory treatment option. More cases need 
to be studied in order to confirm the efficacy of this 
treatment. 
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